Medtronic Plc (MDT) - Financial and Strategic SWOT Analysis Review

September 2021 | 93 pages | ID: M9DF82FB0F0EN
GlobalData

Abstracts

Medtronic Plc (MDT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Medtronic Plc (Medtronic), formerly Medtronic Inc, is a medical technology company that designs, develops, manufactures and markets a wide range of medical devices and solutions for the treatment of heart valve disorders, heart failure, diseases of the coronary artery, aortic, peripheral vascular, venous renal and neurological diseases, spine and musculoskeletal disorders and diseases of the ear, nose and throat. It also provides biologic solutions for the orthopedic and dental markets. In the US, the company sells its products through direct sales force, and in other countries, through direct sales representatives and independent distributors. It serves hospitals, third-party healthcare providers, clinics, institutions including governmental health care programs, distributors, and group purchasing organizations in Asia Pacific, Europe, the Americas, the Middle East and Africa. Medtronic is headquartered in Dublin, Ireland.

Medtronic Plc Key Recent Developments

Sep 28,2021: Apollo Hospitals performs first procedure with Medtronic’s robotic system
Sep 16,2021: Alfred E. Mann Foundation for Scientific Research announces sale of intellectual property and collaboration with Medtronic to develop next-generation implantable insulin pump
Sep 13,2021: Medtronic Collaboration with Mpirik to address disparities in care associated with sudden cardiac arrest
Sep 13,2021: Axonics announces partial decision on inter partes review proceedings
Aug 20,2021: Medtronic Reports First Quarter Fiscal 2022 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Medtronic Plc - Key Facts
Medtronic Plc - Key Employees
Medtronic Plc - Key Employee Biographies
Medtronic Plc - Major Products and Services
Medtronic Plc - History
Medtronic Plc - Company Statement
Medtronic Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Medtronic Plc - Business Description
Business Segment: Cardiovascular Portfolio
Overview
Performance
Business Segment: Diabetes Group
Overview
Performance
Business Segment: Medical Surgical Portfolio
Overview
Performance
Business Segment: Neuroscience Portfolio
Overview
Performance
Geographical Segment: Emerging Markets
Target Markets
Performance
Geographical Segment: Non-US Developed Markets
Target Markets
Performance
Geographical Segment: The US
Target Markets
Performance
R&D Overview
Medtronic Plc - Corporate Strategy
Medtronic Plc - SWOT Analysis
SWOT Analysis - Overview
Medtronic Plc - Strengths
Medtronic Plc - Weaknesses
Medtronic Plc - Opportunities
Medtronic Plc - Threats
Medtronic Plc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Medtronic Plc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Medtronic Plc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Medtronic Plc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Sep 28, 2021: Apollo Hospitals performs first procedure with Medtronic’s robotic system
Sep 16, 2021: Alfred E. Mann Foundation for Scientific Research announces sale of intellectual property and collaboration with Medtronic to develop next-generation implantable insulin pump
Sep 13, 2021: Medtronic Collaboration with Mpirik to address disparities in care associated with sudden cardiac arrest
Sep 13, 2021: Axonics announces partial decision on inter partes review proceedings
Aug 20, 2021: Medtronic Reports First Quarter Fiscal 2022 Financial Results
Aug 05, 2021: dorsaVi extends agreement with Medtronic
Jun 29, 2021: Medtronic launches app-based study to better understand relationship between atrial fibrillation disease burden and impact on patient outcomes
Jun 24, 2021: Medtronic announces retirement of Senior Vice President Bradley E. Lerman and appointment of Jennifer Kirk as principal accounting officer
Jun 18, 2021: Next-generation implants will be biodegradable and non-invasive
May 28, 2021: Medtronic reports 37% increase in Q4 FY21 revenue

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Medtronic Plc, Key Facts
Medtronic Plc, Key Employees
Medtronic Plc, Key Employee Biographies
Medtronic Plc, Major Products and Services
Medtronic Plc, History
Medtronic Plc, Other Locations
Medtronic Plc, Subsidiaries
Medtronic Plc, Key Competitors
Medtronic Plc, Ratios based on current share price
Medtronic Plc, Annual Ratios
Medtronic Plc, Annual Ratios (Cont...1)
Medtronic Plc, Annual Ratios (Cont...2)
Medtronic Plc, Interim Ratios
Medtronic Plc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Medtronic Plc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Medtronic Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Medtronic Plc, Performance Chart (2017 - 2021)
Medtronic Plc, Ratio Charts
Medtronic Plc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Medtronic Plc, Medical Equipment, Deals by Type, 2015 to YTD 2021